Literature DB >> 32138626

The prevalence of Alzheimer's disease in the Chinese Han population: a meta-analysis.

Xingxing Zhao1,2, Xinyi Li3.   

Abstract

Objectives: To evaluate the prevalence of Alzheimer's disease(AD) in China, a meta-analysis was performed.
Methods: All cross-sectional studies on the prevalence of AD conducted from 2001 to 2017 were collected and screened.A random effect model was then used to combine and analyze the data.
Results: The number of studies and the population considered by the present study totaled 29 and 170,138, respectively. Of the latter, 4,452 patients were diagnosed with AD. Our findings indicated the combined prevalence of AD in China was 4% (95%CI:3%-4%), which increased with age. We further found this prevalence to be associated with sex and education: prevalences among men and women were 3% and 5%,respectively,and populations whose attained level of education was elementary school or below and junior middle school or above featured prevalences of 6% and 3%, respectively. The region with the highest prevalence of AD was East China(5%), followed by North China(4%) and Central China(3%); this value was slightly higher in rural(3%); this value was slightly higher in rural(5%) than in urban(4%) districts.conclusion: our study found the combined prevalence of AD in china to be 4%; this prevalence was closely associated with gender,age,level of education attained, and region.

Entities:  

Keywords:  Alzheimer’s disease; China; meta-analysis; prevalence

Mesh:

Year:  2020        PMID: 32138626     DOI: 10.1080/01616412.2020.1716467

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  5 in total

Review 1.  Lipopolysaccharide induced altered signaling pathways in various neurological disorders.

Authors:  Sukhdev Singh; Kuleshwar Sahu; Charan Singh; Arti Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-01-06       Impact factor: 3.000

Review 2.  Alzheimer's Disease: Epidemiology and Clinical Progression.

Authors:  Amir Abbas Tahami Monfared; Michael J Byrnes; Leigh Ann White; Quanwu Zhang
Journal:  Neurol Ther       Date:  2022-03-14

3.  Influence of MRI on Diagnostic Efficacy and Satisfaction of Patients with Alzheimer's Disease.

Authors:  Zheng Dong; Xinyu Yang; Liming Chang; Xin Song; Xiangchun Li; Jiantao Wang; Juntao Li
Journal:  Comput Math Methods Med       Date:  2021-11-08       Impact factor: 2.238

Review 4.  Advances on Therapeutic Strategies for Alzheimer's Disease: From Medicinal Plant to Nanotechnology.

Authors:  Nasser A Hassan; Asma K Alshamari; Allam A Hassan; Mohamed G Elharrif; Abdullah M Alhajri; Mohammed Sattam; Reham R Khattab
Journal:  Molecules       Date:  2022-07-28       Impact factor: 4.927

5.  Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females.

Authors:  Lauren Edwards; Renaud La Joie; Leonardo Iaccarino; Amelia Strom; Suzanne L Baker; Kaitlin B Casaletto; Yann Cobigo; Harli Grant; Minseon Kim; Joel H Kramer; Taylor J Mellinger; Julie Pham; Katherine L Possin; Howard J Rosen; David N Soleimani-Meigooni; Amy Wolf; Bruce L Miller; Gil D Rabinovici
Journal:  Neurobiol Aging       Date:  2021-04-22       Impact factor: 5.133

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.